Ra Pharmaceuticals Inc (RARX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RARX | AMGN | GILD | BIIB | CELG |
| Company | Ra Pharmaceuticals Inc | Amgen Inc | Gilead Sciences Inc | Biogen Inc | Celgene Corp |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 47.99 | 265.64 | 67.01 | 191.75 | 108.01 |
| High | 48.01 | 265.92 | 67.02 | 192.56 | 108.59 |
| Low | 47.98 | 262.58 | 65.90 | 189.52 | 107.27 |
| Last | 48.00 | 262.75 | 66.16 | 190.52 | 108.24 |
| Change | -0.02 | -1.32 | -0.77 | -1.64 | +0.11 |
| % Change | -0.03% | -0.50% | -1.15% | -0.85% | +0.10% |
| Volume | 3,864,600 | 2,082,700 | 6,442,200 | 1,512,000 | 191,230,496 |
| 20-Day Average Volume | 1,869,975 | 2,201,900 | 6,214,910 | 1,111,075 | 16,188,930 |
| Previous Close | 48.01 | 264.07 | 66.93 | 192.16 | 108.13 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | No |
| Technicals | |||||
| 20-Day Moving Average | 46.03 | 272.96 | 70.21 | 206.35 | 108.17 |
| 20-Day Raw Stochastic | 99.68% | 0.65% | 3.10% | 3.10% | 63.25% |
| 20-Day Relative Strength | 56.47% | 36.64% | 27.91% | 26.94% | 64.69% |
| Weighted Alpha | +21.70 | +4.25 | -25.27 | -38.74 | +46.30 |
| Today's Opinion | 56% Buy | 56% Sell | 100% Sell | 100% Sell | 100% Buy |
| Previous Opinion | 56% Buy | 56% Sell | 100% Sell | 100% Sell | 100% Buy |
| Last Month's Opinion | 80% Buy | 8% Sell | 88% Sell | 100% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.91% since 03/25/20 | -2.69% since 04/11/24 | -3.63% since 04/11/24 | -6.46% since 04/11/24 | -1.97% since 11/13/19 |
| Low | 46.34 on 03/26/20 | 262.58 on 04/18/24 | 65.90 on 04/18/24 | 189.52 on 04/18/24 | 107.27 on 11/20/19 |
| High | 48.02 on 03/31/20 | 270.93 on 04/15/24 | 68.62 on 04/12/24 | 205.24 on 04/12/24 | 110.53 on 11/14/19 |
| 1-Month | |||||
| %Chg | +2.64% since 02/28/20 | -3.01% since 03/18/24 | -9.69% since 03/18/24 | -13.16% since 03/18/24 | +5.14% since 10/18/19 |
| Low | 40.30 on 03/18/20 | 262.58 on 04/18/24 | 65.90 on 04/18/24 | 189.52 on 04/18/24 | 102.40 on 10/21/19 |
| High | 48.02 on 03/31/20 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 221.74 on 03/21/24 | 110.70 on 11/13/19 |
| 3-Month | |||||
| %Chg | +2.27% since 12/31/19 | -13.71% since 01/18/24 | -23.43% since 01/18/24 | -22.86% since 01/18/24 | +13.63% since 08/20/19 |
| Low | 40.30 on 03/18/20 | 262.58 on 04/18/24 | 65.90 on 04/18/24 | 189.52 on 04/18/24 | 93.41 on 08/23/19 |
| High | 48.02 on 03/31/20 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 252.17 on 01/22/24 | 110.70 on 11/13/19 |
| 6-Month | |||||
| %Chg | +112.27% since 10/01/19 | -7.35% since 10/18/23 | -16.96% since 10/18/23 | -27.70% since 10/18/23 | +14.14% since 05/20/19 |
| Low | 22.25 on 10/08/19 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 189.52 on 04/18/24 | 89.08 on 07/23/19 |
| High | 48.02 on 03/31/20 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 268.30 on 01/03/24 | 110.70 on 11/13/19 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,271,555 | 141,520,144 | 83,333,008 | 27,932,570 | 77,035,920 |
| Shares Outstanding, K | 47,329 | 535,919 | 1,245,077 | 145,361 | 711,714 |
| Annual Sales | 3,000,000 | 28,190,000,000 | 27,116,000,000 | 9,835,600,000 | 15,281,000,000 |
| Annual Net Income | -102,690,000 | 6,717,000,000 | 5,665,000,000 | 1,161,100,000 | 4,046,000,000 |
| Last Quarter Sales | 3,000,000 | 8,196,000,000 | 7,114,000,000 | 2,386,300,000 | 4,520,000,000 |
| Last Quarter Net Income | -24,980,000 | 767,000,000 | 1,429,000,000 | 249,700,000 | 1,691,000,000 |
| 60-Month Beta | 1.04 | 0.58 | 0.19 | -0.02 | 1.41 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.95 on 02/13/24 | 2.99 on 10/31/19 |
| Latest Earnings Date | 05/14/20 | 05/02/24 | 04/25/24 | 04/24/24 | 10/31/19 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.24 | 10.02 | 13.25 | 10.99 |